ReviewJournal of thoracic disease2020

Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors.

Justin A Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.